Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Leparc

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of the Florida Medical Association|July 1, 1991
Informed consent for blood transfusionG F Leparc
Vox Sanguinis|March 3, 1998
Hypotensive reactions associated with platelet transfusions and angiotensin-converting enzyme inhibitorsB Mair, G F Leparc
Critical Reviews in Clinical Laboratory Sciences|January 1, 1991
Leukocyte-poor blood components: issues and indicationsB Lichtiger, G F Leparc
Southern Medical Journal|March 1, 1987
Autologous transfusion: a community blood bank experienceG F Leparc, P J Schmidt
Infectious Diseases in Obstetrics and Gynecology|January 1, 1995
Lewis phenotype in women with preterm labor and premature rupture of the membranesW F O'Brien, G F Leparc, J Holbrook
Transfusion|July 1, 1988
Comparison of assays for anti-HBc in blood donorsP J Schmidt, G F Leparc, C T Samia
Transfusion|May 1, 1989
Impact of explicit questions about high-risk activities on donor attitudes and donor deferral patterns. Results in two community blood centersA J Silvergleid, G F Leparc, P J Schmidt
Surgery, Gynecology & Obstetrics|September 1, 1988
Use of Rh positive blood in emergency situationsP J Schmidt, G F Leparc, C T Samia
American Journal of Clinical Pathology|August 1, 1996
Prevention of transfusion-associated cytomegalovirus infection. Practice parameter. American Society of Clinical PathologistsD Przepiorka, G F LeParc, J Werch, et al.
Transfusion|July 1, 2004
Particulate matter phenomenon: adverse event data and the effect of leukofiltrationSharyn L Orton, G F Leparc, Susan Rossmann, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of the Florida Medical Association|July 1, 1991
Informed consent for blood transfusionG F Leparc
Vox Sanguinis|March 3, 1998
Hypotensive reactions associated with platelet transfusions and angiotensin-converting enzyme inhibitorsB Mair, G F Leparc
Critical Reviews in Clinical Laboratory Sciences|January 1, 1991
Leukocyte-poor blood components: issues and indicationsB Lichtiger, G F Leparc
Southern Medical Journal|March 1, 1987
Autologous transfusion: a community blood bank experienceG F Leparc, P J Schmidt
Infectious Diseases in Obstetrics and Gynecology|January 1, 1995
Lewis phenotype in women with preterm labor and premature rupture of the membranesW F O'Brien, G F Leparc, J Holbrook
Transfusion|July 1, 1988
Comparison of assays for anti-HBc in blood donorsP J Schmidt, G F Leparc, C T Samia
Transfusion|May 1, 1989
Impact of explicit questions about high-risk activities on donor attitudes and donor deferral patterns. Results in two community blood centersA J Silvergleid, G F Leparc, P J Schmidt
Surgery, Gynecology & Obstetrics|September 1, 1988
Use of Rh positive blood in emergency situationsP J Schmidt, G F Leparc, C T Samia
American Journal of Clinical Pathology|August 1, 1996
Prevention of transfusion-associated cytomegalovirus infection. Practice parameter. American Society of Clinical PathologistsD Przepiorka, G F LeParc, J Werch, et al.
Transfusion|July 1, 2004
Particulate matter phenomenon: adverse event data and the effect of leukofiltrationSharyn L Orton, G F Leparc, Susan Rossmann, et al.
Pageof 2